PlainPill

Ketamine

Also known as Esketamine, Spravato

The short answer. More people than not who report on Ketamine say it helped (65% of 65). It is most often used for mood: 97% of 62 reports say that improved. It is well studied — 854 meta-analyses on PubMed.

What users report
65%helped65 reports · medium confidence
42 helped17 mixed6 didn't help

From 141 mentions in total — the rest didn't say how it went and aren't counted.

Clinical research
AStrong research base
854
meta-analyses
1,957
RCTs
26,900
papers
Prescription medication. These are self-reported experiences, not dosing or treatment advice. Prescription drugs have real side effects and interactions — start, stop or change them only with a doctor. Share of positive reports is not a measure of safety.

What Ketamine does, according to users

Of the people who reported each effect, the share who said it got better.

What the research says

Systematic reviews and meta-analyses from PubMed, with their published conclusions.

AStrong research base

3+ meta-analyses or systematic reviews and 10+ randomized controlled trials in humans. The grade measures how much human research exists — read the conclusions below for what it found. 854 meta-analyses on PubMed ↗ · 1,957 randomized trials ↗

Crit Care Med · 2025 · Meta-analysis / systematic review
Ketamine Versus Etomidate for Rapid Sequence Intubation: A Systematic Review and Meta-Analysis of Randomized Trials

Conclusion: Compared with etomidate, ketamine probably results in more hemodynamic instability during the peri-intubation period and appears to have no effect on successful intubation on the first attempt or mortality. However, ketamine results in decreased need for the initiation of vasopressor use and decreases adrenal suppression compared with etomidate.

PubMed 39570063 ↗
Am J Psychiatry · 2025 · Meta-analysis / systematic review
Esketamine Treatment for Depression in Adults: A PRISMA Systematic Review and Meta-Analysis

Conclusion: The study findings suggest that esketamine's efficacy as an add-on to antidepressants is modest in treatment-resistant depression (similar to augmentation strategies with atypical antipsychotics) and is absent against suicidality itself. These findings need to be considered in light of esketamine's abuse potential and the fact that long-term effects are still not fully known. Some alarming signs concerning deaths and emerging suicidality during the testing phase are discussed, along with other regulatory issues.

PubMed 39876682 ↗
Registered clinical trials

1,900 human trials on ClinicalTrials.gov test Ketamine — 966 completed, 212 recruiting now. See all on ClinicalTrials.gov ↗

What government agencies say

Official records from US, Canadian and EU regulators, each linked to its source.

US legal status (DEA)

Ketamine is a Schedule III controlled substance in the US. DEA controlled-substance list ↗

FDA drug label

The current US prescription label has no boxed warning.

Full label on DailyMed (NIH) ↗

FDA recalls

42 recalls of products named for Ketamine. Most recent:

  • 2026-05-06 · Class II: cGMP deviations. record ↗
  • 2026-02-18 · Class II: Lack of Assurance of Sterility record ↗
  • 2025-10-22 · Class III: Labeling: Incorrect or Missing Lot and/or Exp Date record ↗

Class I = could cause serious harm; Class II = temporary or reversible harm; Class III = unlikely to cause harm. Recalls are of specific products and lots, not of the ingredient itself. All recalls (openFDA) ↗

Reports to the FDA about the drug (FAERS)

4,846 adverse-event reports mention Ketamine. Most often reported:

  • Infusion site pain · 733
  • Drug ineffective · 526
  • Off label use · 509
  • Nausea · 503
  • Infusion site erythema · 462
  • Headache · 319

Reports often involve several drugs and serious illness; a report doesn't prove the drug caused the problem, and these counts can't tell you how often it happens. Source query (openFDA) ↗

Liver safety (LiverTox, NIH)

LiverTox rates Ketamine B — a highly likely cause of liver injury (12–50 published cases). LiverTox entry ↗

US government research funding (NIH)

NIH has funded 83 research projects with Ketamine in the title, $115,871,256 in total (1985–2026). NIH RePORTER ↗

Plain-language guides from the US government: MedlinePlus: Ketamine Injection ↗

Dosage people report

We don't list doses for prescription medications. Dosing should only come from a doctor or pharmacist.

Reported side effects

How often each side effect came up across all reports.

dissociation ×2headache ×1fatigue ×1insomnia ×1weakness ×1memory issues ×1numbing ×1psychosis ×1

What users say

First-hand experiences, quoted verbatim. We show one positive and one negative where both exist.

“One thing that has really helped me tremendously, without the nasty side effects of SSRIs, is Ketamine infusions.”
HelpedRead the discussion ↗
“killed my anxiety and elevated my mood a lot when it stopped acting...had an abnormality on my kidneys (elevated creatinine)”
MixedRead the discussion ↗
“Esketamine treatment for 9 months helped me tremendously again anxiety when i was at my worst.”
HelpedRead the discussion ↗
“I don't know much about ketamine, but it helps my depression better than anything I've ever tried.”
HelpedRead the discussion ↗
Read more Ketamine reviews →
Top discussions (5)

Ketamine compared

Other options for mood

Sources

User data from public discussions; research from PubMed. Information only, not medical advice — talk to a doctor before starting, stopping or combining anything. Data updated October 5, 2026. How we rate